News

LB Pharmaceuticals (LBRX) stock is on track for a Nasdaq listing as the company focused on neuropsychiatric diseases seeks a ...
Patel Retail IPO closed at 95x subscription, raising Rs 242.76 crore. Shares list on BSE and NSE August 26, 2025. Patel’s R ...
Discover Tata Capital’s IPO plans, regulatory deadline, and what’s at stake—read now to stay updated on this high-profile ...
Vikram Solar IPO saw 54.63 times subscription, listing on BSE and NSE expected at Rs 373 with a 12.35 percent premium. FY25 ...
Two small issuers and one SPAC priced offerings this past week, but there was big news in the pipeline, as a few large names ...
Patel Retail IPO was subscribed 95.70 times as the three-day IPO drew to a close on Thursday. And now the investor focus has ...
Vikran Engineering's IPO opens on August 26, aiming to raise ₹772 crore with a price band of ₹92–97 per share. It has a grey ...
Big first-day gains by recent high-profile US listings have raised questions over whether Wall Street banks – wary of ...
In 2024, when IPO fundraising soared to a five-year high of ₹1.60 lakh crore, OFS remained strong at ₹95,285 crore. The fresh ...
Ethos Ltd. ( ($IN:ETHOSLTD) ) just unveiled an announcement. Ethos Limited has announced the publication of notices in ...
Molbio Diagnostics, backed by Temasek & Motilal Oswal, files IPO papers with Sebi. IPO includes fresh issue & offer-for-sale.
Temasek Holdings subsidiary, and Motilal Oswal Private Equity-backed Molbio Diagnostics IPO | The company is planning to tap capital markets to raise Rs 200 crore via fresh issue, and the remaining ...